英文名稱 |
中文名稱 |
CAS號 |
操作 |
1-PHENYL-PIPERIDIN-2-ONE |
N-苯基-2-哌啶酮 |
4789-09-7 |
詳細
|
Pilaralisib (XL-147) |
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺?;鵠苯基]-2-甲基丙酰胺 |
934526-89-3 |
詳細
|
Taselisib |
GDC 0032 |
1282512-48-4 |
詳細
|
A-1210477 |
A-1210477 |
1668553-26-1 |
詳細
|
EPZ015666 |
EPZ015666 |
1616391-65-1 |
詳細
|
2,4,6-TRIMETHYLANISOLE |
2,4,6-三甲基苯甲醚 |
4028-66-4 |
詳細
|
EPZ004777 |
EPZ004777 |
1338466-77-5 |
詳細
|
Ceralasertib |
AZD6738 |
1352226-88-0 |
詳細
|
EPZ020411 |
EPZ020411 鹽酸鹽的形式 |
1700663-41-7 |
詳細
|
GSK591 |
GSK591 (EPZ-015866) |
1616391-87-7 |
詳細
|
4-Bromo-2-nitrobenzyl alcohol |
4-溴-2-硝基芐醇 |
22996-19-6 |
詳細
|
Pinometostat |
(2R,3R,4S,5R)-2-(6-氨基-9H-嘌呤-9-基)-5-((((1R,3S)-3-(2-(6-(叔丁基)-1H-苯并[D]咪唑-2-基)乙基)環(huán)丁基)(異丙基)氨基)甲基)四氫呋喃-3,4-二醇 |
1380288-87-8 |
詳細
|
pyridin-2-amine 1-oxide monohydrochloride |
吡啶-2-胺 1-氧化物單鹽酸鹽 |
57097-28-6 |
詳細
|
Afuresertib hydrochloride |
N-((S)-1-氨基-3-(3-氟苯基)丙-2-基)-5-氯-4-(4-氯-1-甲基-1H-吡唑-5-基)噻吩-2-甲酰胺鹽酸鹽 |
1047645-82-8 |
詳細
|
3,5-Dimethyl-4-hydroxybenzenemethanol |
4-(羥甲基)-2,6-二甲酚 |
4397-14-2 |
詳細
|
Carbamic acid, N-[4-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)butyl]-, 1,1-dimethylethyl ester |
叔丁基(4-(1,3-二氧異喹啉-2-基)氨基甲酸酯 |
188957-09-7 |
詳細
|
N-(2-CYANOETHYL)-PHTHALIMIDE |
N-(2-氰基乙基)鄰苯二甲酰亞胺 |
3589-45-5 |
詳細
|
CPI-169 |
化合物CPI169 |
1450655-76-1 |
詳細
|
1,3-DIOXO-2-ISOINDOLINEETHANESULFONIC ACID, POTASSIUM SALT |
1,3-DIOXO-2-ISOINDOLINEETHANESULFONIC ACID, POTASSIUM SALT |
91893-72-0 |
詳細
|
N-(4-Aminobutyl)-phthalimide HCl |
2-(4-氨基丁基)-2,3-二氫-1H-異吲哚-1,3-二酮鹽酸鹽 |
35517-18-1 |
詳細
|
CPI-203 |
CPI-203 |
1446144-04-2 |
詳細
|
Tirabrutinib |
替拉魯替尼 |
1351636-18-4 |
詳細
|
Sonidegib |
索尼吉布 |
956697-53-3 |
詳細
|
AMG-337 |
AMG-337 |
1173699-31-4 |
詳細
|
AZD3965 |
AZD3965 |
1448671-31-5 |
詳細
|
N-Boc-4-Methylene-L-proline Methyl Ester |
N-BOC-4-亞甲基-L-脯氨酸甲酯 |
84348-39-0 |
詳細
|
N-(CINNAMOYL)-3-METHOXYANILINE |
N-(肉桂酰)-3-甲氧基苯胺 |
127033-74-3 |
詳細
|
DIAZOXIDE |
氯甲苯噻嗪 |
364-98-7 |
詳細
|
GSK2656157 |
GSK2656157 |
1337532-29-2 |
詳細
|
Mavelertinib |
PF-06747775 |
1776112-90-3 |
詳細
|
2-(3-Methoxypyridin-4-yl)ethanaMine |
3-甲氧基-4-乙氨基吡啶 |
1060801-82-2 |
詳細
|
MK-8033 |
MK-8033 |
1001917-37-8 |
詳細
|
QUINOLINE-4-CARBOXYLIC ACID HYDRAZIDE |
異喹啉-4-硫代羧酸酰胺 |
435271-32-2 |
詳細
|
CUDC-427 |
1446182-94-0 |
1446182-94-0 |
詳細
|
3-Bromo-N-Boc-DL-phenylalanine methyl ester |
3-(3-溴苯基)-2-(叔丁氧羰基)氨基)丙酸甲酯 |
1822475-70-6 |
詳細
|
Ribociclib hydrochloride |
7-環(huán)戊基-N,N-二甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]-7H-吡咯并[2,3-D]嘧啶-6-甲酰胺鹽酸鹽 |
1211443-80-9 |
詳細
|
(2S,3R,4S,5S)-5-(chloromethyl)tetrahydrofuran-2,3,4-triyl triacetate |
(2S,3R,4S,5S)-2,3,4-三乙?;?5-氯甲基四氫呋喃 |
185453-73-0 |
詳細
|
Carbamic acid, 1H-indol-2-yl-, 1,1-dimethylethyl ester (9CI) |
(1H-吲哚-2-基)氨基甲酸叔丁酯 |
167954-49-6 |
詳細
|
LY2157299 (Galunisertib) |
LY 2157299 |
700874-72-2 |
詳細
|
BGT226 |
BGT226 |
915020-55-2 |
詳細
|
CHEMBRDG-BB 4012656 |
(2,2,6,6-四甲基-哌啶-4-基)-甲胺 |
62995-79-3 |
詳細
|
Vistusertib (AZD-2014) |
3-[2,4-雙((3S)-3-甲基嗎啉-4-基)吡啶并[5,6-E]嘧啶-7-基]-N-甲基苯甲酰胺 |
1009298-59-2 |
詳細
|
CCT-251921 |
CCT251921 |
1607837-31-9 |
詳細
|
BGB-102 |
17-溴-1,8,9,10,11,12,13,14-八氫-20-甲氧基-13-甲基-4,6-乙烯橋嘧啶并[4,5-B][6,1,12]苯并氧雜二氮雜環(huán)十五碳七烯 |
807640-87-5 |
詳細
|
TAK-243 (MLN7243) |
TAK-243 |
1450833-55-2 |
詳細
|
4-Methyl-1,2,3,6-tetrahydropyridine hydrochloride |
4-甲基-1,2,3,6-四氫吡啶鹽酸鹽 |
95019-16-2 |
詳細
|
CB-5083 |
CB5083 |
1542705-92-9 |
詳細
|
TAK-580 (MLN2480) |
MLN2480 |
1096708-71-2 |
詳細
|
2-b]pyridine |
3-溴呋喃[3,2-B]吡啶 |
92404-63-2 |
詳細
|
BAY1125976 |
CS-2913 |
1402608-02-9 |
詳細
|
(2S,5R)-2,5-DIMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
(2S,5R)-1-N-BOC-2,5-二甲基哌嗪 |
548762-66-9 |
詳細
|
Volasertib |
N-[反式-4-[4-(環(huán)丙基甲基)-1-哌嗪基]環(huán)己基]-4-[[(7R)-7-乙基-5,6,7,8-四氫-5-甲基-8-異丙基-6-氧代-2-蝶啶基]氨基]-3-甲氧基苯甲酰胺 |
755038-65-4 |
詳細
|
Taladegib |
4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺 |
1258861-20-9 |
詳細
|
BAY 87-2243 |
BAY87-2243 |
1227158-85-1 |
詳細
|
METHYL 5-CYANO-2-METHOXYBENZOATE |
5-氰基-2-甲氧基苯甲酸甲酯 |
40757-12-8 |
詳細
|
(2-[(TERT-BUTOXYCARBONYL)AMINO]PYRIDIN-3-YL)BORONIC ACID |
2-(叔丁氧羰基氨基)吡啶-3-硼酸 |
863753-35-9 |
詳細
|
PI3K-IN-32 |
PIK抑制劑 |
371934-59-7 |
詳細
|
Acalisib |
GS-9820 |
870281-34-8 |
詳細
|
6-AMINO-2,4-DIMETHYL-3-PYRIDINECARBONITRILE |
6-氨基-2,4-二甲基-3-吡啶腈 |
769-27-7 |
詳細
|
ABC294640 |
奧帕尼布 |
915385-81-8 |
詳細
|
LCL-161 |
LCL161 |
1005342-46-0 |
詳細
|
BAY1143572 |
ATUVECICLIB RACEMATE (BAY-1143572 RACEMATE) |
1414943-88-6 |
詳細
|
CCT251545 |
CCT251545 |
1661839-45-7 |
詳細
|
Zoligratinib |
DEBIO-1347 |
1265229-25-1 |
詳細
|
1-(2-(3-formyl-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
1-(2-(3-甲酰基-N-甲基苯甲酰氨基)乙基)哌啶-4-基[1,1'-聯(lián)苯]-2-基氨基甲酸酯 |
864760-28-1 |
詳細
|
4'-Aminobiphenyl-4-carbonitrile |
4'-氨基-4-氰基聯(lián)苯 |
4854-84-6 |
詳細
|
piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
哌啶-4-基 [1,1-聯(lián)苯]-2-氨基甲酸酯 |
171722-92-2 |
詳細
|
Adavosertib |
MK-1775 |
955365-80-7 |
詳細
|
RO4929097 |
N1-[(7S)-6,7-二氫-6-氧代-5H-二苯并[B,D]氮雜卓-7-基]-2,2-二甲基-N3-(2,2,3,3,3-五氟丙基)丙二酰胺 |
847925-91-1 |
詳細
|
Futibatinib |
FGFR抑制劑(FGFR-IN-1) |
1448169-71-8 |
詳細
|
5,7-dichloro-3,4-dihydro-2,6(1H)-Isoquinolinedicarboxylic acid, 2-(1,1-dimethylethyl) 6-methyl ester |
2-N-BOC-5,7-二氯-3,4-二氫-異喹啉-6-甲酸甲酯 |
851784-80-0 |
詳細
|
1,3-bis(2-phenylphenyl)urea |
雷芬那辛雜質(zhì)10 |
115293-14-6 |
詳細
|
Fisogatinib |
BLU554 |
1707289-21-1 |
詳細
|
Fedratinib (TG101348) |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-26-8 |
詳細
|
1-benzylpiperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
1-benzylpiperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
171723-80-1 |
詳細
|
benzyl-(2-chloroethyl)-methyl-azanium chloride |
N-(2-氯乙基)-N-甲基芐胺鹽酸鹽 |
23510-18-1 |
詳細
|
piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate Hydrochloride |
哌啶-4-基 [1,1'-聯(lián)苯]-2-基氨基甲酸酯鹽酸鹽 |
1205552-76-6 |
詳細
|
Brilanestrant |
(E)-3-(4-((E)-2-(2-CHLORO-4-FLUOROPHENYL)-1-(1H-INDAZOL-5-YL)BUT-1-EN-1-YL)PHENYL)ACRYLIC ACID |
1365888-06-7 |
詳細
|
Dacomitinib |
達克替尼 |
1110813-31-4 |
詳細
|
CFI-400945 fumarate |
1616420-30-4 |
1616420-30-4 |
詳細
|
4-[[5-Fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]-2-pyrimidinyl]amino]phenyl][(3S)-3-(methylamino)-1-pyrrolidinyl]Methanone |
[4-[[5-氟-4-[2-甲基-1-(1-甲基乙基)-1H-咪唑-5-基]-2-嘧啶基]氨基]苯基][(3S)-3-(甲氨基)-1-吡咯烷]甲酮 |
924641-59-8 |
詳細
|
Nirogacestat |
PF-3084014 |
1290543-63-3 |
詳細
|
(S)-methyl 3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate |
(S)-methyl 3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate |
546115-43-9 |
詳細
|
GDC-0941 (Pictilisib) |
GDC-0941 |
957054-30-7 |
詳細
|
1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
864686-28-2 |
864686-28-2 |
詳細
|
Vismodegib |
維莫德吉 |
879085-55-9 |
詳細
|
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
1-(2-(甲基氨基)乙基)哌啶-4-基[1,1'-聯(lián)苯基]-2-基氨基甲酸酯 |
743460-48-2 |
詳細
|
MK-0752 |
順式-4-[(4-氯苯基)磺?;鵠-4-(2,5-二氟苯基)環(huán)己烷丙酸 |
471905-41-6 |
詳細
|
GDC-0980 (Apitolisib) |
(S)-1-[4-[[2-(2-氨基嘧啶-5-基)-7-甲基-4-(嗎啉-4-基)噻吩并[3,2-D]嘧啶-6-基]甲基]哌嗪-1-基]-2-羥基丙-1-酮 |
1032754-93-0 |
詳細
|
1-Piperidinecarboxylic acid, 4-[[([1,1'-biphenyl]-2-ylamino)carbonyl]oxy]-, 1,1-dimethylethyl ester |
4-([1,1'-聯(lián)苯]-2-基氨基甲?;?氧基)哌啶-1-甲酸叔丁酯 |
2098067-87-7 |
詳細
|
Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-(hydroxymethyl)benzoyl]methylamino]ethyl]-4-piperidinyl ester |
雷芬那新雜質(zhì)1 |
1682660-39-4 |
詳細
|
METHYL BIPHENYL-2-CARBOXYLATE |
2-羧酸聯(lián)苯甲酯 |
16605-99-5 |
詳細
|
TERT-BUTYL 3-AMINOBENZOATE |
3-氨基苯甲酸叔丁酯 |
92146-82-2 |
詳細
|
FIIN-2 |
FIIN-2 |
1633044-56-0 |
詳細
|
5-cyano-2-methoxybenzoic acid |
5-cyano-2-methoxybenzoic acid |
84923-71-7 |
詳細
|
N-Formyl N,N-Didesmethyl Sibutramine |
N-{1-[1-(4-氯苯基)環(huán)丁基]-3-甲基丁基}-甲酰胺 |
84467-85-6 |
詳細
|
RN983 |
化合物 T34337 |
1423129-83-2 |
詳細
|
2-(4-chlorophenyl)-N-ethyl-N,2,5-trimethylhexan -3-amine hydrochloride |
2-(4-氯苯基)-N-乙基-N,2,5-三甲基己-3-胺鹽酸鹽 |
935888-80-5 |
詳細
|
5,5-dimethyl-2-phenyl-morpholine |
5,5-二甲基-2-苯基嗎啉 |
42013-48-9 |
詳細
|
D-Phenylalanine, 3-bromo-N-[(1,1-dimethylethoxy)carbonyl]-, methyl ester |
(R)-3-(3-溴苯基)-2-(叔丁氧羰基)氨基)丙酸甲酯 |
2244592-10-5 |
詳細
|